iota Biosciences Analysis: $16M Raised
What is iota Biosciences?
iota Biosciences, a wholly-owned subsidiary of Astellas Pharma US, develops pioneering bioelectronic devices for disease treatment and management. The company builds on award-winning ultrasound technology from UC Berkeley to create safe and effective diagnostic and therapeutic devices. Its focus includes brain-machine interfaces, nerve interfaces, and implantable electroceuticals.
Location
Alameda, United States
Employees
51-200
Founded
2017
Product Features & Capabilities
- Bioelectronic devices for neuroengineering
- Nerve interface systems
- Brain-machine interface technology
- Ultrasound-based diagnostic tools
- Implantable electroceuticals
Use Cases
Enable real-time monitoring of neural activity for Parkinson’s patients; Facilitate targeted nerve stimulation for chronic pain management; Provide diagnostic ultrasound imaging for early detection of neurological disorders; Support implantable devices for long-term disease monitoring; Develop closed-loop systems for responsive treatment of epilepsy
How much iota Biosciences raised
Funding - $16M
Other Considerations
Wholly-owned subsidiary of Astellas Pharma US; Founded in 2017; Based in Alameda, California; BSI Assurance Certified; Specializes in ultrasound-based bioelectronics and nerve interfaces
See something that needs updating? Suggest edits to this profile.